Advertisement

Topics

EUSA Pharma (USA), Inc. Company Profile

16:42 EDT 19th September 2017 | BioPortfolio


News Articles [2309 Associated News Articles listed on BioPortfolio]

European Commission approves EUSA Pharma’s dinutuximab beta for neuroblastoma

EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, has announced that the European Commission has approved Dinutuximab beta for the treatment...

EUSA Pharma wins accelerated approval for rare cancer drug

UK-based specialty pharmaceutical company EUSA Pharma has received European approval for the immunotherapy…

EUSA Pharma looks to further in-licensing to build growth

Specialist company EUSA Pharma is looking for new medicines to develop after getting two cancer drugs recommended by European regulators this year. The UK-based company has had its dinutuximab beta ...

EU approves EUSA's kidney cancer drug

EUSA Pharma's Fotivda, or tivozanib, was approved by the European Commission as a first-line treatment for adult patients wit -More- 

EUSA's pediatric neuroblastoma drug gets EU OK

EUSA Pharma's monoclonal chimeric antibody dinutuximab beta has been approved by European regulators as a treatment for high- -More- 

EUSA Pharma approval fills gap in neuroblastoma market

EUSA Pharma’s dinutuximab beta has gained European approval for its immunotherapy for children affected by a rare and devastating form of cancer, a move which exploits a gap in the market left after...

AVEO Oncology Announces Receipt of Payments from EUSA Pharma and CANbridge

Wednesday, September 13th 2017 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– AVEO Oncology (NASDAQ:AVEO) today announced the receipt of a $4 million research and development payment fro...

EUSA Pharma receives EC approval for dinutuximab beta antibody to treat neuroblastoma

EUSA Pharma has secured European Commission (EC) approval for the antibody ch14.18/CHO, (dinutuximab beta) to be used in treating high-risk neuroblastoma in patients older than a year.

Drugs and Medications [241 Associated Drugs and Medications listed on BioPortfolio]

Dihydrocodeine bitartrate and aspirin and caffeine [EUSA Pharma (USA), Inc.]

Dihydrocodeine bitartrate and aspirin and caffeine

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [32 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials Series - Large Pharma.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [719 Associated Companies listed on BioPortfolio]

EUSA Pharma Inc

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The ...

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The ...

EUSA Pharma (USA), Inc.

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "EUSA Pharma (USA), Inc." on BioPortfolio

We have published hundreds of EUSA Pharma (USA), Inc. news stories on BioPortfolio along with dozens of EUSA Pharma (USA), Inc. Clinical Trials and PubMed Articles about EUSA Pharma (USA), Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EUSA Pharma (USA), Inc. Companies in our database. You can also find out about relevant EUSA Pharma (USA), Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record